NYSE · Medical - Care Facilities
ARDT (ARDT) Stock
$10.73
-1.83%
NYSE: ARDT
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
UnitedHealth to Top Second-Quarter Earnings Views on Favorable Utilization Trends, Morgan Stanley Says
MT Newswires · Jun 30, 2026
Do Options Traders Know Something About Ardent Health Stock We Don't?
Zacks · Jun 29, 2026
Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares?
Motley Fool · Jun 12, 2026
Spotlight On Undervalued Small Caps With Insider Activity In June 2026
Simply Wall St. · Jun 10, 2026
Will Ardent Health’s (ARDT) New CEO Shift the Focus of Its Post-IPO Efficiency Narrative?
Simply Wall St. · Jun 7, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About ARDT
ARDT is led by CEO Martin J. Bonick, employs 19,200 people, headquartered in US, publicly traded since 2024.
ARDT stock trades at $10.73 with a market capitalization of $1.54B. The stock is valued at a price-to-earnings (P/E) ratio of 10.45, price-to-book of 0.85, price-to-sales of 0.23. Over the past 52 weeks the stock has ranged between $7.71 and $15.48, and currently trades 30.7% below its 52-week high.
On profitability, ARDT generates a return on equity (ROE) of 8.07%, return on capital employed of 19.35%, an operating margin of 5.15%, a net profit margin of 2.09%.